Photo via Semafor

Klomp wins over Democrat in bid to be No. 2 HHS official

Read the original at Semafor ↗
Cite

Lim, D. (2026, September 25). Klomp wins over Democrat in bid to be No. 2 HHS official. Semafor. https://www.semafor.com/article/09/25/2026/klomp-wins-over-democrat-in-bid-to-be-no-2-hhs-official

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Semafor · collected 2026-09-25 · by David Lim

Quick Summary

Chris Klomp’s nomination to become the deputy secretary at the Department of Health and Human Services (HHS) has moved forward with Senate support from 14 Republicans and one Democrat, Sheldon Whitehouse of Rhode Island. Whitehouse cited ongoing issues related to Medicare reimbursement in his state as a reason for supporting Klomp’s confirmation. He believes Klomp can assist in resolving longstanding challenges faced by Rhode Island healthcare providers due to CMS compensation policies.
Written by AI on 2026-09-25, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Chris Klomp, who served as President Donald Trump’s negotiator for lowering prescription drug prices through the “most-favored nation” (MFN) deals with pharmaceutical companies, has advanced to be the second-in-command at HHS, after being approved by the Senate Finance Committee on a vote of 15-12. Despite concerns from Democrats, Klomp was nominated in February and quickly rose through the ranks at HHS since Trump’s second term began in 2025. His role involved negotiating with 26 pharmaceutical firms to match U.S. prescription drug prices with those in developing countries. Notably, Democratic Senator Sheldon Whitehouse of Rhode Island joined Republicans to support Klomp's nomination, citing ongoing issues with Medicare reimbursement policies affecting his state.

Written for “HHS Deputy Official Change” on 2026-11-02, grounded in this article and the 1 other(s) covering the same event.

Story

📰 HHS Deputy Official Change
Politics · 2 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads leans right and hedges 0% of its claims. Each row says how that neighbour differs.
Washington Examiner
⚖️ Leans left further left than this Hedges 2 of 23 claims Outlet record 70/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
6
sentences that state something as happening or true
Uncertain
0%
0 of 6 hedged ("reportedly", "may", "according to")
Leaning
Leans right
of the writing, not the subject · beta estimate
Publisher signals
59/100
Semafor's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-25 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Semafor · 1406 article(s) · 3 correction(s) detected
Running correction rate · 3 correction(s)

Who wrote this

David Lim
13 article(s) here · 1 carrying a prediction
🔮 The slowdown could happen in a number of ways, GOP aides working on health policy told me — depending on how big an election night Democrats have.
🔮 But the food industry has raised concerns over what impact the forthcoming proposed definition could have on lawsuits across the country, and the White House is still scheduled to meet separately with several groups to discuss the issue in the coming weeks — including the National Restaurant Association on Tuesday, the Center for Food Safety on Thursday, and the Consumer Brands Association and Flavor and Extract Manufacturers Association in the days after the midterms.
🔮 Now the question is whether Kennedy could reconsolidate the same voters if he launches a new bid for the presidency.
2026-10-22 · assertive framing · The fight for MAHA's soul
🔮 A pending regulation under White House review could expand access to peptides, largely unregulated substances that are popular with wellness influencers and Health and Human Services Secretary Robert F. Kennedy Jr. In July, a panel of outside advisers to the Food and Drug Administration — which included individuals with connections to the peptide industry — narrowly recommended adding several peptides to the agency’s list of products that can be compounded, or mixed at pharmacies, despite concerns from FDA scientists.
🔮 If Republicans ultimately support her, Overton will lead the agency responsible for vaccine policy after making a bigger contribution to the Trump administration’s effort to reverse decades of American policy on childhood vaccines than was widely understood.
🔮 With Sens. Roger Marshall, R-Kansas, and Susan Collins, R-Maine, fighting difficult reelection battles, it’s unclear who will replace Louisiana Sen. Bill Cassidy as the top Republican on the Senate HELP Committee.
🔮 When asked about his vote, Whitehouse pointed to a longstanding Rhode Island Medicare reimbursement policy issue he said he hopes Klomp will help resolve.
🔮 The Trump administration is backing off its initial plan for an executive order that would give the president greater influence over decisionmaking on National Institutes of Health grants, according to three people familiar with the process.
🔮 “You can imagine if here in the U.S., in Europe, we knew this Bundibugyo for 19 years, the vaccine would already be available,” Kaseya said.
🔮 President Trump took a victory lap on his administration’s work on drug pricing today, announcing all 50 states will participate in the “most-favored-nation” program, saying “this one thing alone should win us the midterms.”
2026-09-18 · assertive framing · Health wonks question who saves in Trump drug program
Also by David Lim
The fight for MAHA's soul
2026-10-22 · Semafor
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 13 articles by David Lim →

Topics

Democrat HHS R.I. Republicans Senate

Subjects

Whitehouse PERSON · 3× Klomp PERSON · 2× Chris Klomp’s PERSON · 1× Democrat NORP · 1× Donald Trump PERSON · 1× HHS ORG · 1× R.I. GPE · 1× Republicans NORP · 1× Senate ORG · 1× Sheldon Whitehouse PERSON · 1×

Narrative

“And I’m prepared to make a bet that Chris Klomp will help Administrator [Mehmet] Oz and Secretary [Robert F.] Kennedy [Jr.] towards a resolution of this very dire home-based problem.”
framing: assertive · carried by 1 article(s) · first seen 2026-09-25
🔮 When asked about his vote, Whitehouse pointed to a longstanding Rhode Island Medicare reimbursement policy issue he said he hopes Klomp will help resolve.
2026-09-25 · Semafor
Klomp wins over Democrat in bid to be No. 2 HHS official · assertive framing

Claims (6 extracted, 0 hedged)

Chris Klomp’s nomination to be the second-in-command at HHS has advanced to the Senate floor — with help from one Democrat. asserted
nomination → advance → Democrat
Sen. Sheldon Whitehouse, D-R.I., often a vocal critic of President Donald Trump, joined 14 Republicans to support Klomp. asserted
Whitehouse → join → Klomp
When asked about his vote, Whitehouse pointed to a longstanding Rhode Island Medicare reimbursement policy issue he said he hopes Klomp will help resolve. asserted
Klomp → ask → issue
For years, Whitehouse’s state has been grappling with challenges stemming from how the Centers for Medicare and Medicaid Services compensates healthcare providers. asserted
Centers → grapple → providers
“I’m sick of it, and it’s really hurting my home state,” Whitehouse told Semafor. asserted
Whitehouse → ’m → Semafor
“And I’m prepared to make a bet that Chris Klomp will help Administrator [Mehmet] Oz and Secretary [Robert F.] Kennedy [Jr.] towards a resolution of this very dire home-based problem.” asserted
Klomp → ’m → problem
💬Give feedback
🕘History 🎫Support